Medicines Evaluation Unit

Medicines Evaluation Unit is one of the UK’s leading independent contract research organizations specializing in early-phase clinical trials, particularly for respiratory and inflammatory diseases. It operates state-of-the-art hospital-based facilities with MHRA Phase I accreditation since 2009, offering services such as study management, protocol development, data management, quality assurance, and bioanalytical services. MEU is at the forefront of testing new climate-friendly inhalers to support the transition to low global warming potential propellants. Over its history it has conducted more than 150 studies with no critical or major findings from regulatory inspections.